Junior Research Group

Epithelium Microbiome lnteractions

  • Immunology, Infection and Cancer
  • Junior Research Group
Employee image

Dr. Jens Puschhof

In the EMIL group, we study how bacteria contribute to cancer development, metastasis and treatment response. Our team includes cancer researchers, tissue engineers, microbiologists and bioinformaticians working together to help patients by deciphering the functional impacts of bacteria in human tumors.

Logo DKFZ

Our Research

In the EMIL group, we study how bacteria contribute to cancer development, metastasis and treatment response. Our team includes cancer researchers, tissue engineers, microbiologists and bioinformaticians working together to help patients by deciphering the functional impacts of bacteria in human tumors. 

Using tissue samples from patients, we isolate bacterial strains and create organoids. These models can be combined with additional features of the human gut on USB stick-sized devices, “organ chips”, for detailed studies. We further transplant organoid-bacteria mixtures into mouse models to study their migration and interaction in a whole body context.

In our unique biobank at DKFZ, we characterize both tumor organoids and tumor-resident bacterial strains through whole genome sequencing, fluorescence microscopy and other cutting-edge methods. Based on the diverse data obtained, we develop hypotheses about how specific bacterial species might influence tumors. With our broad portfolio of patient-derived models and assays, our main focus lies on building a deep understanding of these relationships. Through close collaborations with clinical partners, we work towards the rapid translation of our findings towards new microbiome-based detection, prevention and treatment strategies of cancer.

If you like working in or collaborating with a young team with flat hierarchies, a collaborative spirit and a keen interest in functional cancer microenvironment work, please get in touch!

Projects

In the METABAC project, we investigate how bacteria contribute to the process of metastasis. Using patient-derived organoids, organ chips and organoid xenotransplantations, we study how specific bacterial strains shape the multiple steps of the metastatic cascade.

Team

  • Employee image

    Dr. Jens Puschhof

  • Employee image

    Julia Ide

  • Employee image

    Melanie Jordan

  • Employee image

    Sven Leisen

  • Employee image

    Kamil Moskal

    PhD Student

  • Employee image

    Luigi Lukas Nardella

    PhD Student

  • Employee image

    Kyanna Ouyang

    PhD Student

  • Employee image

    Lena Schorr

    PhD Student

  • Employee image

    Nina Stinchcombe

  • Employee image

    Timon Utecht

Entire Team

Selected Publications

2024 - The International Journal of cancer

Modeling cancer-microbiome interactions in vitro – a guide to co-culture platforms.

2024 - Nature

Sticky situation as bacteria drive colon cancer.

2020 - Nature
2021 - Nature Protocols
2024 - Cancer Cell
2023 - NPJ Biofilms and Microbiomes

Get in touch with us

Employee image
Dr. Jens Puschhof
Form

Form data is loaded ...